A role for TGF-β1-induced cellular responses during wound healing of the non-scarring early human fetus?

Journal of Investigative Dermatology

Volumn 127, Issue 11, 2007, Pages 2656-2667

  Rolfe, Kerstin J ^a   Richardson, Janette ^a   Vigor, Charlotte ^a   Irvine, Laurie M ^b   Grobbelaar, Addie O ^a   Linge, Claire ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b WATFORD GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; MESSENGER RNA; MITOGENIC AGENT; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL DIFFERENTIATION; CELL REGENERATION; CELLULAR DISTRIBUTION; COLLAGEN SYNTHESIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; MYOFIBROBLAST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCAR FORMATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WOUND HEALING; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DERMIS; DRUG EFFECT; FIBROBLAST; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; REGENERATION; SCAR;

CELL DIFFERENTIATION; CELLS, CULTURED; CICATRIX; COLLAGEN TYPE I; DERMIS; FETUS; FIBROBLASTS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; REGENERATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 35348839573     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700951     Document Type: Article

References (58)

1. Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K (2004) Impaired Smad7-Smurf mediated negative regulation of TGF-β signaling in scleroderma fibroblasts. J Clin Invest 113:253-64
2. Cass DL, Sylvester KG, Yang EY, Crombleholme TM, Adzick NS (1997) Myofibroblast persistence in fetal sheep wounds is associated with scar formation. J Pediatr Surg 32:1017-21
3. Chen W, Fu XB, Sheng ZY (2002) Review of current progress in the structure and function of Smad proteins. Chin Med J (Eng) 115:446-50
4. Chin BY, Petrache I, Choi AMK, Choi ME (1999) Transforming growth factor β1 rescues serum deprivation-induced apoptosis via the mitogen activated protein kinase (MAPK) pathway in macrophages. J Biol Chem 274:11362-8
5. Clark DA, Coker R (1998) Transforming growth factor-beta. Int J Biochem Cell Biol 30:293-8
6. Cowin AJ, Holmes TM, Brosnan P, Fergurson MWJ (2001) Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds. Eur J Dermatol 11:424-31
7. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ (1995) Defective haematopoiesis and vasulogenesis in transforming growth factor-beta1 knock out mice. Development 121:1845-54
8. Dixon M, Agius L, Yeaman SJ, Day CP (1999) Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucogon is associated with inhibition of ERK2 and p70 S6 kinase. Hepatology 29:1418-24
9. Eickelberg O, Kohler E, Reichenberger F, Bertschin S, Woodtli T, Erne P et al. (1999) Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-β1 and TGF-β3. Am J Physiol 276:L814-7
10. Engel ME, McDonnell MA, Law BK, Moses HL (1999) Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J Biol Chem 274:37413-20
11. Estes JM, Vande Berg JS, Adzick NS, MacGillivray TE, Desmoulière A, Gabbiani G (1994) Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 56:173-81
12. Evans RA, Tian YC, Steadman R, Phillips AO (2003) TGF-β1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res 282:90-100
13. Frank S, Madlener M, Werner S (1996) Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 271:10188-93
14. Funaba M, Zimmerman CM, Mathews LS (2002) Modulation of Smad2-mediated signaling by extracellular signal regulated kinase. J Biol Chem 277:41361-8
15. Hartsough MT, Mulder KM (1995) Transforming growth factor beta activation of p44 MAPK in proliferating cultures of epithelial cells. J Biol Chem 270:7117-24
16. 2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 163:152-7
17. Hocevar BA, Brown TL, Howe PH (1999) TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18:1345-56
18. Huwiler A, Pfeilschifter J (1994) Transforming growth factor beta 2 stimulates active and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells. FEBS Lett 354:255-8
19. Ihara S, Motobayashi Y, Nagao E, Kistler A (1990) Ontogenetic transition of wound healing pattern in rat skin occurring at the fetal stage. Development 114:253-9
20. Inman GJ, Nicolás FJ, Hill CS (2002) Nucleocytoplasmic shuttling of Smads 2,3, and 4 permits sensing of TGF-β receptor activity. Mol Cell 10:283-94
21. Javelaud D, Laboureau J, Gabison E, Verrecchia F, Mauviel A (2003) Disruption of basal JNK activity differentially affects key fibroblast functions important for wound healing. J Biol Chem 278:24624-8
22. Kaartinen V, Voncken JW, Schuler C, Warburton D, Bu D, Heisterkamp N et al. (1995) Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11:415-21
23. Leask A, Abraham DJ (2004) TGF-β signaling and the fibrotic response. FASEB J 18:816-27
24. Levine JH, Moses HL, Gold LI, Nanney LB (1993) Spatial and temporal patterns of immunoreactive transforming growth factor β1, β2, and β3 during excisional wound repair. Am J Pathol 143:368-80
25. Longaker MT, Whitby DJ, Jennings RW, Duncan BW, Ferguson MW, Harrison MR et al. (1991) Fetal diaphragmatic wounds heal with scar formation. J Surg Res 50:375-85
26. Lorenz HP, Lin RY, Longaker MT, Whitby DJ, Adzick NS (1995) The fetal fibroblast: the effector cell of scarless fetal repair. Plast Reconstr Surg 96:1251-9
27. Luukko K, Ylikorkala A, Mäkelä TP (2001) Developmentally regulated expression of Smad3, Smad4, Smad6, and Smad7 involved in TGF-beta signalling. Mech Dev 101:209-12
28. Martin P, Dickson MC, Millan FA, Akhurst RJ (1993) Rapid induction and clearance of TGFβ1 is an early response to wounding in the mouse embryo. Dev Genet 14:225-38
29. Massague J, Wotton D (2000) Transcriptional control by the TGFβ/Smad signaling system. EMBO J 19:1745-54
30. McCluskey J, Martin P (1995) Analysis of tissue movements of embryonic wound healing-DiI studies in the limb bud stage mouse embryos. Dev Biol 170:102-14
31. Meuli M, Lorenz HP, Hedrick MH, Sullivan KM, Harrison MR, Adzick NS (1995) Scar formation in the fetal alimentary tract. J Pediatr Surg 30:392-5
32. Mori Y, Chen S-J, Varga J (2000) Modulation of endogenous Smad expression in normal skin fibroblasts by Transforming growth factor-β. Exp Cell Res 258:374-83
33. Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J (2004) Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor β responses in skin fibroblasts. Arthritis Rheum 50:4008-21
34. Moustakas A (2002) Smad signaling network. J Cell Sci 115:3355-6
35. Moustakas A, Souchelnytskyi S, Heldin CH (2001) Smad regulation in TGF-beta signal transduction. J Cell Sci 114:4359-69
36. Musci I, Skorecki KL, Goldberg HJ (1996) Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-β1 on gene expression. J Biol Chem 271:16567-72
37. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E et al. (1997) TGF-β receptor mediated signaling through Smad2, Smad3, and Smad4. EMBO J 16:5353-62
38. Nicolás FJ, Hill CS (2003) Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest. Oncogene 22:3698-711
39. Overall CM, Wrana JL, Sodek J (1989) Independent regulation of collagenase, 72kDa progelatinase, and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 264:1860-9
40. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36
41. Pratsinis H, Giannouli CC, Zervolea I, Psarras S, Stathakos D, Kletsas D (2004) Differential proliferative response of fetal and adult human skin fibroblasts to transforming growth factor-β. Wound Repair Regen 12:374-83
42. Reunanen N, Foschi M, Han J, Kähäri VM (2000) Activation of extracellular signal-regulated kinase 1/2 inhibits type I collagen expression by human skin fibroblasts. J Biol Chem 275:34634-9
43. Rowlatt U (1979) Intrauterine wound healing in a 20 week human fetus. Virchows Arch A Pathol Anat Histol 381:353-61
44. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP et al. (1997) TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 124:2659-70
45. Serini G, Bochaton-Piallat M, Ropraz P, Geinoz A, Borsi L, Zardi L et al. (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1. J Cell Biol 142:873-81
46. Shah M, Foreman DM, Fergurson MW (1992) Control of scarring in adult wounds by neutralising antibody to transforming growth factor β. Lancet 339:213-4
47. 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107:1137-57
48. Shah M, Foreman DM, Fergurson MW (1995) Neutralization of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108:985-1002
49. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M et al. (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693-9
50. Soo C, Beanes SR, Hu F-Y, Zhang X, Dang C, Chang G et al. (2003) Ontogenetic transition in fetal wound transforming growth factor-β regulation correlates with collagen organization. Am J Pathol 163:2459-76
51. Soo C, Hu F-Y, Zhang X, Wang Y, Beanes SR, Lorenz HP et al. (2000) Differential expression of fibromodulin, a transforming growth factor-β modulator, in fetal skin development and scarless repair. Am J Pathol 157:423-33
52. 2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-β1 in human lung fibroblasts. Am J Respir Cell Mol Biol 28:754-61
53. Varga R, Jimenez SA (1987) Transforming growth factor beta causes a persistent increase in steady-state amounts for type I and type III collagen and fibronectin mRNAs in normal dermal human fibroblasts. Biochem J 297:597-604
54. Vrljicak P, Myburgh D, Ryan AK, van Rooijen MA, Mummery CL, Gupta IR (2004) Smad expression during kidney development. Am J Physiol Renal Physiol 286:F625-33
55. Walker GA, Guerrero IA, Leinward LA (2001) Myofibroblasts: molecular crossdressers. Curr Top Dev Biol 51:91-107
56. Whitman M (1998) Smads and early developmental signaling by the TGFβ superfamily. Genes Dev 12:2445-62
57. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanism of activation of the TGF-beta receptor. Nature 370:341-7
58. Zhu H-J, Iaria J, Sizeland AM (1999) Smad7 differentially regulates transforming growth factor β-mediated signaling pathways. J Biol Chem 274:32258-64